I agree that this site is using cookies. You can find further informations here.
X
Paracha, Noman
35  results:
Search for persons X
?
1

Supporting Biomarker-Driven Therapies in Oncology: A Genomi..:

Stenzinger, Albrecht ; Cuffel, Brian ; Paracha, Noman...
The Oncologist.  28 (2023)  5 - p. e242-e253 , 2023
Link: https://doi.org/10.1093/..
 
?
2

Comparison of Alternative Methods to Assess the Cost-Effect..:

Briggs, Andrew ; Wehler, Beth ; Gaultney, Jennifer G....
Value in Health.  25 (2022)  6 - p. 1002-1009 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Correction to: Systematic Literature Review to Assess Econo..:

Paracha, Noman ; Hudson, Pollyanna ; Mitchell, Stephen.
PharmacoEconomics.  40 (2022)  S1 - p. 119-119 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Indirect Treatment Comparison of Larotrectinib versus Entre..:

Garcia-Foncillas, Jesus ; Bokemeyer, Carsten ; Italiano, Antoine...
Cancers.  14 (2022)  7 - p. 1793 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Systematic Literature Review to Identify Utility Values in ..:

Sutherland, C. Simone ; Hudson, Pollyanna ; Mitchell, Stephen.
PharmacoEconomics.  40 (2021)  S1 - p. 39-67 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Estimating Treatment-Switching Bias in a Randomized Clinica..:

Kuehne, Felicitas ; Rochau, Ursula ; Paracha, Noman...
Medical Decision Making.  42 (2021)  2 - p. 194-207 , 2021
Link: https://doi.org/10.1177/..
 
?
7

Systematic Literature Review to Assess the Cost and Resourc..:

Paracha, Noman ; Hudson, Pollyanna ; Mitchell, Stephen.
PharmacoEconomics.  40 (2021)  S1 - p. 11-38 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Systematic Literature Review to Assess Economic Evaluations..:

Paracha, Noman ; Hudson, Pollyanna ; Mitchell, Stephen.
PharmacoEconomics.  40 (2021)  S1 - p. 69-89 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Estimating Long-Term Survival Outcomes for Tumor-Agnostic T..:

Briggs, Andrew ; Paracha, Noman ; Rosettie, Katherine...
Oncology.  100 (2021)  2 - p. 124-130 , 2021
Link: https://doi.org/10.1159/..
 
?
10

Mixture Cure Models in Oncology: A Tutorial and Practical G..:

Felizzi, Federico ; Paracha, Noman ; Pöhlmann, Johannes.
PharmacoEconomics - Open.  5 (2021)  2 - p. 143-155 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Preferences and Utilities for Treatment Attributes in Type ..:

Lo, Siu Hing ; Gorni, Ksenija ; Sutherland, C. Simone...
PharmacoEconomics.  40 (2021)  S1 - p. 91-102 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Evaluating the clinical effectiveness and safety of various..:

Paracha, Noman ; Reyes, Adriana ; Diéras, Véronique...
Breast Cancer Research and Treatment.  180 (2020)  3 - p. 597-609 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Cost-effectiveness of atezolizumab versus docetaxel and niv..:

Marine, Sivignon ; Stéphane, Roze ; Nicolas, Plommet...
Journal of Medical Economics.  23 (2020)  5 - p. 464-473 , 2020
Link: https://doi.org/10.1080/..
 
?
14

Systematic review of health state utility values in metasta..:

Paracha, Noman ; Abdulla, Ahmed ; MacGilchrist, Katherine S.
Health and Quality of Life Outcomes.  16 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
15

Accounting for Uncertainty in Decision Analytic Models Usin..:

Bennett, Iain ; Paracha, Noman ; Abrams, Keith.
Value in Health.  21 (2018)  1 - p. 105-109 , 2018
Link: https://doi.org/10.1016/..
 
1-15